Can oils derived from genetically-modified plants replace fish oil as a source of long chain n-3 polyunsaturated fatty acids in the human diet?
Can oils derived from genetically-modified plants replace fish oil as a source of long chain n-3 polyunsaturated fatty acids in the human diet?
批准号:
BB/N014081/1
负责人:
Graham Burdge
金额:
$66.7万
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2016
资助国家:
英国
项目状态:
已结题
起止时间:
2016 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Omega-3 fats called EPA and DHA are known to be beneficial to human health. They lower the chance of getting heart disease and can control the symptoms of conditions that involve inflammation such as arthritis. The main food source of EPA and DHA is fatty fish like salmon and sardines. EPA and DHA are also found in fish oil supplements. The UK government recommends that people consume EPA and DHA regularly in order to stay healthy, particularly during ageing. However, many people do not follow these recommendations, partly because they do not like to eat fatty fish or find it too expensive. Also, there are not enough fish in in the sea to provide everyone in the world with enough EPA and DHA to stay healthy, and fish stocks are declining. Therefore, there is a need to find a sustainable source of EPA and DHA that can be increased in order to meet the need for these healthy fats. Research sponsored by the BBSRC has led to the development of plants that can make EPA and DHA. This has been achieved by inserting the genes needed for making EPA and DHA into plants that do not normally have those genes. The oil produced in the seeds of these so-called transgenic plants contains similar amounts of EPA and DHA to fish oils. Therefore, it is possible that this seed oil could be used to replace fatty fish and fish oil supplements as a sustainable and inexpensive source of EPA and DHA. However, the structure of the oil produced by the plants is different from that of fish oils, and it is not known whether this difference would result in the plant oil being a better or worse source of EPA and DHA for people. It is important to know this, because if the plant oil was less effective than fish oil in increasing the amount of EPA and DHA in people's blood and tissues, and in benefiting health, then it may be less attractive as a source of EPA and DHA in the diet. This project will determine whether the plant oil is as effective as fish oil in changing the amounts of EPA and DHA in the blood and in modifying some processes that are related to health. In the latter regard, we plan to study the concentrations of fats like cholesterol in the blood and the ability of immune cells taken from the blood to respond when stimulated in the laboratory. We will address our aims in two ways. First, we will recruit healthy men and women in two age groups (18 to 30 years or 50 to 65 years) to take part in a study that involves consuming a single meal containing either fish oil or new plant oil. We will then take a series of blood samples over the following 8 hours. This will allow us to assess whether EPA and DHA derived from the plant oil are absorbed as efficiently by the gut as when they are provided as fish oil. We will also compare the effect of the two oils on the levels of fat and on substances involved in immune function in blood. Second, we will recruit another group of healthy volunteers as above, and provide them with fish oil or plant oil as a dietary supplement to take over 8 weeks. We will take blood samples after 4 and 8 weeks and compare the effect of the different oils on the levels of EPA and DHA in blood and in blood cells. We will also compare the effect of these oils on immune function, the levels of fat in blood, and on the activity of genes in white blood cells. The findings will show whether the plant oil is as effective as fish oil in raising the levels of EPA and DHA in blood and in changing immune function. We expect that the findings of this project will provide strong evidence for or against using the plant oil as a replacement for fish oil. Furthermore, these results will contribute to the continuing debate about the introduction of transgenic crops into agricultural practice. Ultimately, we hope that a positive outcome will lead to the use of the plant oil as a major source of EPA and DHA in the UK diet as this would have important positive implications for marine ecology and for health of the UK population.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Postprandial incorporation of EPA and DHA from transgenic Camelina sativa oil into blood lipids is equivalent to that from fish oil in healthy humans.
转基因亚麻荠油中的 EPA 和 DHA 餐后进入血脂的含量与健康人鱼油中的含量相当。
DOI:
10.1017/s0007114519000825
发表时间:
2019
期刊:
The British journal of nutrition
影响因子:
--
作者:
[West AL]
通讯作者:
West AL
Transgenic Camelina sativa seed oil is an effective dietary source of eicosapentaenoic and docosahexaenoic acid for humans.
转基因亚麻荠籽油是人类二十碳五烯酸和二十二碳六烯酸的有效膳食来源。
DOI:
--
发表时间:
2021
期刊:
JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY
影响因子:
2
作者:
[West Annette]
通讯作者:
West Annette
DOI:
10.1017/s0007114520002044
发表时间:
2020-11-14
期刊:
The British journal of nutrition
影响因子:
--
作者:
[West AL, Miles EA, Lillycrop KA, Han L, Napier JA, Calder PC, Burdge GC]
通讯作者:
Burdge GC
Differential postprandial incorporation of 20:5n-3 and 22:6n-3 into individual plasma triacylglycerol and phosphatidylcholine molecular species in humans.
餐后将 20:5n-3 和 22:6n-3 差异化地掺入人体个体血浆三酰甘油和磷脂酰胆碱分子种类中。
DOI:
10.1016/j.bbalip.2020.158710
发表时间:
2020
期刊:
Biochimica et biophysica acta. Molecular and cell biology of lipids
影响因子:
--
作者:
[West AL]
通讯作者:
West AL
How does polyunsaturated fatty acid biosynthesis regulate T lymphocyte function?
-
批准号:BB/S00548X/1
-
项目类别:Research Grant
-
资助金额:$64.97万
-
财政年份:2019
-
负责人:Graham Burdge
-
依托单位:
Epigenetic processes in transmission of prenatally-induced phenotypes between generations
-
批准号:BB/F013043/1
-
项目类别:Research Grant
-
资助金额:$59.0万
-
财政年份:2008
-
负责人:Graham Burdge
-
依托单位:
国内基金
海外基金
登录
查看更多内容
tRNA-derived small RNA上调YBX1/CCL5通路参与硼替佐米诱导慢性疼痛的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:张祥忠
-
依托单位:
一类DMOA-Derived Meroterpenoid的全合成研究
-
批准号:22071192
-
项目类别:面上项目
-
资助金额:63.0万元
-
批准年份:2020
-
负责人:胡向东
-
依托单位:
TET1/exosome-derived miR-22-3p/BTG1信号轴在膀胱癌化疗耐药中的作用与分子机制
-
批准号:82072807
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:肖峻
-
依托单位:
基于寨卡病毒NS1和NS5的海洋微生物中抗病毒化合物的发现
-
批准号:81973204
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2019
-
负责人:宋福行
-
依托单位:
基于肝炎病毒嗜肝性对hESC-derived hepatocytes 体外分化过程中的关键因子分析
-
批准号:81870432
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:周小玲
-
依托单位:
hESC-derived hepatocytes 中抗HBV干扰素反应模式及关键ISGs 的功能分析
-
批准号:81570567
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2015
-
负责人:周小玲
-
依托单位:
脂肪组织来源干细胞促进颗粒脂肪游离移植后再血管化机制的实验研究
-
批准号:81171834
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:鲁峰
-
依托单位:
肌源干细胞促进神经肌肉再生机制的实验研究
-
批准号:81100950
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:张盈帆
-
依托单位:
基于脂肪干细胞的同种异体肌腱缺损修复及机制
-
批准号:81101359
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:邓丹
-
依托单位:
脂肪来源干细胞诱导尿路上皮细胞及其机制的研究
-
批准号:81070605
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2010
-
负责人:卢慕峻
-
依托单位: